Advances in research into Alzheimer's disease

July 9, 2011 in Diseases, Conditions, Syndromes

Advances in research into Alzheimer's disease: transporter proteins at the blood CSF barrier and vitamin D may help prevent amyloid β build up in the brain

Advancing age is a major risk factor for Alzheimer's disease and is associated with build- up of the peptide amyloid β in the . New research published in BioMed Central's open access journal Fluids and Barriers of the CNS shows that removal of amyloid β from the brain depends on and also on an age-related alteration in the production of transporter proteins which move amyloid β in and out of the brain.

Low levels of vitamin D are thought to be involved in age-related decline in memory and cognition and are also associated with Alzheimer's disease. Researchers from Tohoku University, Japan, looked at the mechanism behind this and found that vitamin D injections improved the removal of amyloid β from the brain of mice.

Prof Tetsuya Terasaki said, "Vitamin D appears increase transport of amyloid β across the blood brain barrier (BBB) by regulating protein expression, via the vitamin D receptor, and also by regulating cell signaling via the MEK pathway. These results lead the way towards new therapeutic targets in the search for prevention of Alzheimer's disease."

The transport of amyloid β across the BBB is known to be orchestrated by transporter proteins such as LRP-1 and P-gp, which move amyloid β out of the brain, and RAGE, which controls influx. Looking at the transport of amyloid β from blood to cerebrospinal fluid (CSF), and from CSF to blood, researchers from Rhode Island Hospital and The Warren Alpert Medical School, found that LRP-1 and P-gp at the blood-cerebrospinal fluid barrier (BCSFB), increased with age so increasing removal of amyloid β from the CSF and brain.

Prof Gerald Silverberg said, "While increased production of at the CSF barrier may help amyloid β removal from the older brain, production of these proteins eventually fails. This failure may be an important event in brain function as we age and for people with ."

More information: 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier, Shingo Ito, Sumio Ohtsuki, Yasuko Nezu, Yusuke Koitabashi, Sho Murata and Tetsuya Terasaki, Fluids and Barriers of the CNS (in press)

Provided by BioMed Central search and more info website

5 /5 (3 votes)  

Rank 5 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Physicians definitively links irritable bowel syndrome and bacteria in gut

An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold ...

Diseases, Conditions, Syndromes created 21 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Study provides compelling evidence for an effective new treatment for tinnitus

According to new research, a multidisciplinary approach to treating tinnitus that combines cognitive behaviour therapy with sound-based tinnitus retraining therapy is significantly more effective than currently available ...

Diseases, Conditions, Syndromes created 15 hours ago | popularity not rated yet | comments 0

Infections may be deadly for many dialysis patients

An infection called peritonitis commonly arises in the weeks before many dialysis patients die, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings sugges ...

Diseases, Conditions, Syndromes created 17 hours ago | popularity not rated yet | comments 0

Obese patients face increased risk of kidney damage after heart surgery

Oxidative stress may put obese patients at increased risk of developing kidney damage after heart surgery, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Effect ...

Diseases, Conditions, Syndromes created 17 hours ago | popularity not rated yet | comments 0

New test shows potential for detecting active cases of Lyme disease

George Mason University researchers can find out if a tick bite means Lyme disease well before the bite victim begins to show symptoms.

Diseases, Conditions, Syndromes created 21 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast


First study to suggest that the immune system may protect against Alzheimer's changes in humans

Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.

Phone contact with nurses linked with better outcomes for women with gestational diabetes

Among women with gestational diabetes mellitus, referral to a telephone-based nurse management program was associated with lower risk of high baby birth weight and increased postpartum glucose testing, according to Kaiser ...

WHO target to cut early chronic illness deaths

The World Health Organization announced on Friday it was set to approve a new target to reduce premature deaths from chronic illnesses such as heart disease by a quarter by 2025.

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Questionable research practices surprisingly common

(Medical Xpress) -- Not all scientific misconduct is flat-out fraud. Much falls into the murkier realm of “questionable research practices.” A new study finds that in one field, psychology, these practices are surprisingly ...

Researchers identify key brain cell in antidepressant action

(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.